Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Regencell Bioscience Holdings Ltd fell by 4.85m. Cash Flow from Financing totalled 134.91k or -- of revenues. In addition the company used 4.96m for operations while cash from investing totalled 58.98k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.781 |
---|---|
Tangible book value per share | 0.781 |
More ▼
Balance sheet in USDView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼